English | Español
Patient Daily | Jul 22, 2026

AI data becomes a key issue in biopharma deal negotiations
Patient Daily | Jul 22, 2026

Summit and Akeso report new Western data on ivonescimab in lung cancer trial
Patient Daily | Jul 22, 2026

Experimental neurointerventional technique shows promise for severe back pain
Patient Daily | Jul 22, 2026

Repligen announces $1.5 billion acquisition of BioLife Solutions for cell therapy products
Patient Daily | Jul 22, 2026

Survey shows many Americans uncertain about CDC pregnancy vaccine recommendations
Patient Daily | Jul 22, 2026

Study links higher red meat intake to increased pancreatic cancer risk
Patient Daily | Jul 22, 2026

Transitioning from large pharmaceutical firms to specialty pharma shifts focus to patient proximity
Patient Daily | Jul 22, 2026

Mayday Fund announces 2026-2027 Pain and Society Fellowship class

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
L. R. Alvarez | Jul 30, 2026

TPA's Ross Marchand on 340B: 'Taxpayers are picking up the tab for the program's many failures and mission creep'
+ Regulatory
G. N. Ball | Aug 5, 2026

Citizens Against Government Waste on 340B: 'Covered hospitals now generate millions of dollars of profit'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes